Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
neurology
central nervous system disorders |
| gptkbp:foundedYear |
2001
|
| gptkbp:headquartersLocation |
gptkb:Kansas_City,_Missouri,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Teva Neuroscience
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Nuvigil
gptkb:Azilect gptkb:Copaxone |
| gptkbp:parentCompany |
gptkb:Teva_Pharmaceutical_Industries
|
| gptkbp:specializesIn |
Parkinson's disease treatments
multiple sclerosis treatments |
| gptkbp:subsidiary |
gptkb:Teva_Pharmaceutical_Industries
|
| gptkbp:website |
https://www.tevaneuro.com/
|
| gptkbp:bfsParent |
gptkb:TEVA
|
| gptkbp:bfsLayer |
6
|